McDavid Stilwell | Vice President of Corporate Communications and Investor Relations |
Sandy Macrae | Chief Executive Officer |
Curt Herberts | Chief Business Officer |
Kathy Yi | Chief Financial Officer |
Ed Conner | Chief Medical Officer |
Michael Holmes | Vice President of Research |
Charles Duncan | Piper Jaffray |
Maury Raycroft | Jefferies |
Gena Wang | Barclays |
Yanan Zhu | Wells Fargo |
Good afternoon, and welcome to the Sangamo Therapeutics teleconference to discuss fourth quarter and full year 2017 financial results. This call is being recorded. I will now pass you over to the coordinator of this event, McDavid Stilwell, Vice President of Corporate Communications and Investor Relations.
Good morning, and thank you for joining us today.
As we begin, I'd like to point out that we will be referring to a slide presentation this morning.